Jillian Perry | Materials Science | Best Researcher Award

Assist Prof Dr. Jillian Perry | Materials Science | Best Researcher Award

University of North Carolina - Chapel Hill | United States

Author Profile

Google Scholar

🧠 Early Academic Pursuits

Assist. Prof. Dr. Jillian Perry's academic journey began with a Bachelor of Science in Chemical Engineering, awarded Cum Laude from the University of Florida in 2004, with a minor in Chemistry. Building on her solid foundation, she pursued a PhD in Biomedical Engineering at the same university, where she conducted pioneering research on chitosan nanotube synthesis for drug delivery applications. Her dissertation, supervised by Dr. John D. Steward and Dr. Charles R. Martin, laid the groundwork for a career focused on innovative solutions in drug delivery and nanotechnology.

💼 Professional Endeavors

Currently an Assistant Professor at the University of North Carolina’s Eshelman School of Pharmacy, Dr. Perry also contributes to the Center for Nanotechnology in Drug Delivery. Since joining UNC in 2010 as a Postdoctoral Research Associate at the Lineberger Comprehensive Cancer Center, she has been mentored by renowned researchers like Dr. Joseph M. DeSimone. Over the years, she progressed from a Research Associate Scientist to her current position, collaborating on high-impact research in pharmacoengineering and molecular pharmaceutics.

🧬 Contributions and Research Focus

Dr. Perry’s research explores 3D-printed microneedles, transdermal drug delivery systems, and nanoparticle-based cancer immunotherapies. She has authored numerous impactful publications, contributing extensively to fields such as tumor targeting and transdermal vaccination techniques. Her work includes significant studies on hydrogel-based cancer treatments and PRINT nanoparticle technology for enhanced therapeutic delivery.

🏆 Accolades and Recognition

Dr. Perry has been honored with several awards, such as the 2020 Junior Faculty Development Award and the NanoDDS Poster Award in 2018. Her 3D-printed vaccine patch technology received global attention and won the Fast Company’s World Changing Ideas Award in 2022. She was also recognized for her academic excellence with prestigious scholarships like the University Scholars Scholarship and Bright Futures Scholarship during her undergraduate years.

🌍 Impact and Influence

With an H-index of 19 and over 2,130 citations, Dr. Perry’s research has influenced the scientific community's understanding of nanomedicine and drug delivery technologies. Her innovative approaches in microneedle design and 3D printing for vaccine delivery have potential applications beyond academia, transforming practical healthcare delivery methods and advancing public health initiatives worldwide.

📜 Legacy and Future Contributions

As a thought leader in nanotechnology and biopharmaceuticals, Dr. Perry is expected to continue making groundbreaking contributions to transdermal vaccine development and targeted cancer therapies. Her active role in patenting novel drug delivery systems and designing biocompatible materials solidifies her legacy as a researcher committed to pioneering health solutions. Future contributions will likely include further advancements in non-invasive drug delivery and enhanced treatment efficacy in challenging medical fields, paving the way for transformative healthcare solutions.

 

Publications


📄  Development of 3D printed microneedles of varied needle geometries and lengths, designed to improve dermal delivery of topically applied psoriasis treatments

Authors: Pünnel LC, Palmtag M, Lunter DJ, Perry JL
Journal: European Journal of Pharmaceutics and Biopharmaceutics
Year: 2024


📄  3D-printed Lattice Microneedle Array Patches for Tunable and Versatile Intradermal Delivery

Authors: Rajesh NU, Hwang J, Xu Y, Saccone MA, Hung A, Hernandez RAS, Coates IA, Driskill MM, Dulay MT, Jacobson GB, Tian S, Perry JL#, DeSimone JM
Journal: Advanced Materials
 Year: 2024


📄  Development of a biocompatible 3D hydrogel scaffold using CLIP for the delivery of cell therapy to treat recurrent glioblastoma

Authors: Kass L, Morrent T, Zhang Y, DeVane C, Logan J, Tessema A, Perry JL#, Hingtgen SD
 Journal: Bioengineering and Translational Medicine
Year: 2024


📄  3D-Printed Microarray Patches for Transdermal Applications

Authors: Rajesh NU, Coates I, Driskill MM, Dulay MT, Hsiao K, Ilyn D, Jacobson GB, Kwak JW, Lawrence M, Perry JL, Shea CO, Tian SM, DeSimone JM
 Journal: JACS Au
 Year: 2022


📄  Transdermal Vaccination via 3D Printed Microneedles Induces Potent Humoral and Cellular Immunity

Authors: Caudill CL, Perry JL, Illiadis K, Tessema AT, Lee BJ, Mecham BS, Tian S, DeSimone JM
Journal: PNAS
 Year: 2021